logo-loader
viewOventus Medical Ltd

Oventus Medical targeting massive growth in North America with Sleep Apnea treatment

Oventus Medical (ASX: OVN) Managing Director Dr Chris Hart joined Steve Darling from Proactive to discuss the medical device company that has a unique treatment platform for sleep apnea and snoring. Hart telling Proactive about their growth strategy and also about two deals they recently signed with Aeroflow and Careica in Canada.

Quick facts: Oventus Medical Ltd

Price: 0.26 AUD

ASX:OVN
Market: ASX
Market Cap: $41.14 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Oventus Medical Ltd named herein, including the promotion by the Company of Oventus Medical Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian Vanadium confirms ‘exceptional’ vanadium extraction in test work

Australian Vanadium Ltd (ASX:AVL) (OTCMKTS:ATVVF) managing director Vincent Algar speaks to Proactive about recent pilot test-work conducted at the Australian Vanadium Project, which delivered leach extraction of up to 94.7%. The pilot-scale roast and leach testing has confirmed the...

1 hour, 15 minutes ago

2 min read